Illustratum

Illustratum was a UK private healthcare and biotechnology company focused on DARC, a retinal imaging biomarker platform for detecting apoptosing retinal cells and enabling earlier diagnosis and trial monitoring in ophthalmic disease. The company appears to have centered its business on combining a patented biologic imaging agent with algorithmic image analysis to detect cellular-level disease activity, particularly in glaucoma and age-related macular degeneration. Publicly available evidence indicates that Illustratum was incorporated in 2018 and later entered liquidation, with its DARC technology and related commercialization efforts subsequently associated with Novai. Based on the available record, Illustratum should be viewed as a defunct early-stage ophthalmic diagnostics/biomarker company rather than an active therapeutics developer.